fda compounding semaglutide enforcement november 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The FDA has received reports

A rich comfort meal may sound soothing, but fried food, creamy sauces, and greasy takeout may sit heavily

Next, it tells the pancreas to release just enough insulin

Guests who are pregnant, trying to become pregnant, or breastfeeding without appropriate clinical guidance

BPC-157 for Musculoskeletal Injuries Both TB-500 and BPC-157 have been researched for their healing potential in musculoskeletal injuries in animal models

However, Eli Lilly launched its own weight loss pill, orforglipron, marketed as Foundayo, in April

(page 49) The natural craving-crush combo that makes late-night snacking optional and satisfaction inevitable